These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
146 related articles for article (PubMed ID: 8625362)
1. High expression of NKR-P1 is not an absolute requirement for natural killer activity in BDIX rats. Pinard D; Olsson NO; Chambers WH; Martin F Cancer Immunol Immunother; 1996 Jan; 42(1):15-23. PubMed ID: 8625362 [TBL] [Abstract][Full Text] [Related]
2. Characterization of four new monoclonal antibodies that recognize mouse natural killer activation receptors. Kung SK; Su RC; Shannon J; Miller RG Hybridoma; 2001 Apr; 20(2):91-101. PubMed ID: 11394535 [TBL] [Abstract][Full Text] [Related]
3. Differential sensitivity to natural cell-mediated cytotoxicity of two rat colon adenocarcinoma variants differing in their tumorigenicity: identification of the effector cells as natural killer cells. Pelletier H; Olsson NO; Fady C; Reisser D; Lagadec P; Jeannin JF Cancer Immunol Immunother; 1988; 26(3):263-8. PubMed ID: 3383206 [TBL] [Abstract][Full Text] [Related]
4. Initiation and development of experimental autoimmune neuritis in Lewis rats is independent of the cytotoxic capacity of NKR-P1A+ cells. Yu S; Zhu Y; Chen Z; Alheim M; Ljungberg A; Zhu J J Neurosci Res; 2002 Mar; 67(6):823-8. PubMed ID: 11891797 [TBL] [Abstract][Full Text] [Related]
5. Monoclonal antibody to a triggering structure expressed on rat natural killer cells and adherent lymphokine-activated killer cells. Chambers WH; Vujanovic NL; DeLeo AB; Olszowy MW; Herberman RB; Hiserodt JC J Exp Med; 1989 Apr; 169(4):1373-89. PubMed ID: 2466943 [TBL] [Abstract][Full Text] [Related]
6. Human lymphokine-activated killer cells augment immunotherapy of human colon carcinoma xenografts with monoclonal antibody D612. Pendurthi TK; Schlom J; Primus FJ J Immunother (1991); 1991 Feb; 10(1):2-12. PubMed ID: 2012797 [TBL] [Abstract][Full Text] [Related]
7. cis-Diamminedichloroplatinum and 5-fluorouracil are potent inducers of the cytokines and natural killer cell activity in vivo and in vitro. Okamoto M; Kasetani H; Kaji R; Goda H; Ohe G; Yoshida H; Sato M Cancer Immunol Immunother; 1998 Dec; 47(4):233-41. PubMed ID: 9875677 [TBL] [Abstract][Full Text] [Related]
9. Characterization and comparison of the lytic function of NKR-P1+ and NKR-P1-rat natural killer cell clones established from NKR-P1bright/TCR alpha beta-cell lines. Brissette-Storkus C; Appasamy PM; Hayes LA; Kaufman CL; Ildstad ST; Chambers WH Nat Immun; 1995; 14(2):98-113. PubMed ID: 8601077 [TBL] [Abstract][Full Text] [Related]
10. Role of function-associated molecules in target cell lysis: analysis of rat adherent lymphokine-activated killer cells. Jaso-Friedmann L; Leary JH; Evans DL Nat Immun; 1993; 12(6):316-25. PubMed ID: 8268715 [TBL] [Abstract][Full Text] [Related]
11. Lymphokine-activated killer cells in rats: analysis of progenitor and effector cell phenotype and relationship to natural killer cells. Vujanovic NL; Herberman RB; Olszowy MW; Cramer DV; Salup RR; Reynolds CW; Hiserodt JC Cancer Res; 1988 Feb; 48(4):884-90. PubMed ID: 3257412 [TBL] [Abstract][Full Text] [Related]
12. Induction of the nitric oxide-synthesizing pathway in fresh and interleukin 2-cultured rat natural killer cells. Cifone MG; Festuccia C; Cironi L; Cavallo G; Chessa MA; Pensa V; Tubaro E; Santoni A Cell Immunol; 1994 Aug; 157(1):181-94. PubMed ID: 7518750 [TBL] [Abstract][Full Text] [Related]
13. Differential modulation of LAK and ADCC functions of natural killer cells from AK-5 tumor-bearing rats by IL-2, IL-12 and IFN-gamma. Muralikrishna K; Varalakshmi C; Khar A Cytokines Cell Mol Ther; 1997 Mar; 3(1):51-8. PubMed ID: 9287244 [TBL] [Abstract][Full Text] [Related]
14. Growth of MCF-7 human breast carcinoma in severe combined immunodeficient mice: growth suppression by recombinant interleukin-2 treatment and role of lymphokine-activated killer cells. Zhai YF; Esselman WJ; Oakley CS; Chang CC; Welsch CW Cancer Immunol Immunother; 1992; 35(4):237-45. PubMed ID: 1511458 [TBL] [Abstract][Full Text] [Related]
15. Rat spleen dendritic cells express natural killer cell receptor protein 1 (NKR-P1) and have cytotoxic activity to select targets via a Ca2+-dependent mechanism. Josien R; Heslan M; Soulillou JP; Cuturi MC J Exp Med; 1997 Aug; 186(3):467-72. PubMed ID: 9236200 [TBL] [Abstract][Full Text] [Related]
16. Susceptibility of rat colon carcinoma cells to lymphokine activated killer-mediated cytotoxicity is decreased by alpha1,2-fucosylation. Marionneau S; Bureau V; Goupille C; Hallouin F; Rocher J; Vaydie B; Le Pendu J Int J Cancer; 2000 Jun; 86(5):713-7. PubMed ID: 10797295 [TBL] [Abstract][Full Text] [Related]
17. Re-evaluation of the involvement of NK cells and C-type lectin-like NK receptors in modulation of immune responses by multivalent GlcNAc-terminated oligosaccharides. Grobárová V; Benson V; Rozbeský D; Novák P; Cerný J Immunol Lett; 2013; 156(1-2):110-7. PubMed ID: 24076118 [TBL] [Abstract][Full Text] [Related]
18. The NK1.1 antigen in NK-mediated F1 antiparent killing in vitro. Kung SK; Miller RG J Immunol; 1995 Feb; 154(4):1624-33. PubMed ID: 7836747 [TBL] [Abstract][Full Text] [Related]
19. Natural killer and lymphokine-activated killer cell activities from human marrow precursors. II. The effects of IL-3 and IL-4. Keever CA; Pekle K; Gazzola MV; Collins NH; Bourhis JH; Gillio A J Immunol; 1989 Nov; 143(10):3241-9. PubMed ID: 2809200 [TBL] [Abstract][Full Text] [Related]
20. Gelatin sponge model of effector recruitment: tumoricidal activity of adherent and non-adherent lymphokine-activated killer cells after culture in interleukin-2. Akporiaye ET; Barbieri CA; Stewart CC; Bender JG J Leukoc Biol; 1991 Feb; 49(2):189-96. PubMed ID: 1991999 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]